Is It Time To Reconsider HealthEquity (HQY) After Recent Share Price Weakness?
If you are wondering whether HealthEquity at around US$82.40 is a bargain or already pricing in a lot of optimism, […]
Stock Analysis
Is Guardant Health (GH) Attractively Priced After Strong Multi Year Share Price Gains
For investors considering whether Guardant Health at around US$87.60 represents fair value or a potential opportunity, this article examines what
Is It Time To Reassess Cognizant (CTSH) After Its Recent Share Price Slide?
If you are wondering whether Cognizant Technology Solutions is attractively priced right now, the key is understanding what the current
Is It Time To Reassess BlackRock (BLK) After Its Recent Share Price Climb?
Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million individual investors
Stock Analysis
Publix’s 1st-quarter earnings fall, but stock prices rises 80 cents
May 2, 2026, 10:10 a.m. ET Publix raised its stock price to $20.45 per share on May 1, an 80-cent
Stock Analysis
Stryker Stock Testing Price Floor – Buy Now?
Stryker (SYK) stock should be on your watchlist. Here is why – it is currently trading in the support zone
Is It Time To Reassess Okta (OKTA) After A 33% One Year Share Price Slip
This article examines whether Okta, trading at around US$75.78, may be attractively priced or could instead represent a value trap,
Is It Time To Reassess Snowflake (SNOW) After Its Recent Share Price Slide?
If you are wondering whether Snowflake is starting to look interesting at current levels, the key question is how its
Is It Time To Reconsider Teradata (TDC) After Recent Share Price Recovery?
If you are wondering whether Teradata is attractively priced or looking stretched at its current levels, you will want to
Is Zebra Technologies (ZBRA) A Potential Opportunity After Recent Share Price Rebound?
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply